Efficacy and response time to sertraline versus fluoxetiae in the treatment of unipolar major depressive disorder

Journal of Clinical Psychiatry

Volumn 61, Issue 12, 2000, Pages 942-946

  Suri, R A ^a   Altshuler, L L ^a   Rasgon, N L ^a   Calcagno, J L ^a   Frye, M A ^a   Gitlin, M J ^a   Hwang, S ^a   Zuckerbrow Miller, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; FLUOXETINE; LORAZEPAM; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; RESPONSE TIME; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0034534194     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n1209     Document Type: Article

References (15)

1. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression
2. Acute therapy of depression
3. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression
4. Selective serotonin reuptake inhibitor dose titration in the naturalistic setting
5. Antidepressant utilization in managed care: An evaluation of SSRI use in two HMO settings
6. Fluoxetine and sertraline dosages in major depression
7. Chronological milestones to guide drug change: When should clinicians switch antidepressants?
8. Development of a rating scale for primary depressive illness
9. Residual symptoms in depressed patients who respond acutely to fluoxetine
10. High-dose fluoxetine in the treatment of depressed patients not responsive to a standard dose of fluoxetine
11. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: A doubleblind, controlled study
12. Early nonresponse to fluoxetine as predictor of poor 8-week outcome